The longer list of candidate biomarkers includes the top biomarkers from discovery step ( ≥ 90% of scores, n = 28), the top biomarkers from the prioritization step (CFG score ≥ 8, n = 32), and the nominally significant biomarkers after the validation step ( n = 5), for a total of n = 65 probesets ( n = 60 genes).
← all excerpts
Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs.
1
—
—